Evidence map›Paper›PMID 28452994›Full record

ReviewEye (London, England)2017

Oxidative stress and diabetic retinopathy: development and treatment.

G D Calderon, O H Juarez, G E Hernandez, S M Punzo, Z D De la Cruz

Open access · bronzeAbstract readReview
In one paragraph

Review in Eye (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
20.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 242 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Diabetic retinopathy-recommendations for screening and treatment.Wiener medizinische Wochenschrift (1946) · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Diabetic Retinopathy-A Review.Current diabetes reviews · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

G D CalderonLaboratory of Neurochemistry, National Institute of Pediatrics, Mexico City, Mexico.
O H JuarezLaboratory of Pharmacology, National Institute of Pediatrics, Mexico City, Mexico.
G E HernandezLaboratory of Pharmacology, National Institute of Pediatrics, Mexico City, Mexico.
S M PunzoLaboratory of Pharmacology, National Institute of Pediatrics, Mexico City, Mexico.
Z D De la CruzFaculty of Medicine, Department of Pharmacology, National Autonomous University of Mexico, Mexico City, Mexico.
Universidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is the most common microvascular complication in diabetic patients and one of the main causes of acquired blindness in the world. From the 90s until date, the incidence of this complication has increased. Reactive oxygen species (ROS) is a free radical with impaired electron that usually participates in the redox mechanisms of some body molecules such as enzymes, proteins, and so on. In normal biological conditions, ROS is maintained in equilibrium, however its overproduction can lead to biological process called oxidative stress and this is considered the main pathogenesis of DR. The retina is susceptible to ROS because of high-energy demands and exposure to light. When the balance is broken, ROS produces retinal cell injury by interacting with the cellular components. This article describes the possible role of oxidative stress in the development of DR and proposes some treatment options based on its stages. The review of the topic shows that blindness caused by DR can be avoided by early detection and timely treatment.

Indexed as

Adrenal Cortex HormonesAngiogenesis InhibitorsBlindnessDiabetic RetinopathyHumansMass ScreeningOxidative StressReactive Oxygen SpeciesVitrectomyAdrenal Cortex HormonesAngiogenesis InhibitorsReactive Oxygen Species

Identifiers

PMID28452994
PMCPMC5558229
OpenAlexW2609699760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.